Found: 6
Select item for more details and to access through your institution.
Efficacy and Safety of MAO-B Inhibitors Safinamide and Zonisamide in Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Published in:
- CNS Drugs, 2023, v. 37, n. 11, p. 941, doi. 10.1007/s40263-023-01048-x
- By:
- Publication type:
- Article
Current Insights into Diagnosing and Treating Neurotuberculosis in Adults.
- Published in:
- CNS Drugs, 2023, v. 37, n. 11, p. 957, doi. 10.1007/s40263-023-01047-y
- By:
- Publication type:
- Article
A Prospective Longitudinal Study of the Effects of Eslicarbazepine Acetate Treatment on Bone Density and Metabolism in Patients with Focal-Onset Epilepsy.
- Published in:
- CNS Drugs, 2023, v. 37, n. 11, p. 973, doi. 10.1007/s40263-023-01045-0
- By:
- Publication type:
- Article
A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance.
- Published in:
- CNS Drugs, 2023, v. 37, n. 11, p. 981, doi. 10.1007/s40263-023-01046-z
- By:
- Publication type:
- Article
Trends and Differences in Status Epilepticus Treatment of Children and Adults Over 10 Years: A Comparative Study of Medical Records (2012–2021) from a University Hospital in Germany.
- Published in:
- CNS Drugs, 2023, v. 37, n. 11, p. 993, doi. 10.1007/s40263-023-01049-w
- By:
- Publication type:
- Article
Solriamfetol: A Review in Excessive Daytime Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnoea.
- Published in:
- CNS Drugs, 2023, v. 37, n. 11, p. 1009, doi. 10.1007/s40263-023-01040-5
- By:
- Publication type:
- Article